Cognition Therapeutics Funding: $36M Raised, Grant (2022)
Cognition Therapeutics is based in Purchase, NY. It has raised $36M in total funding. Latest round: Grant.
Cognition Therapeutics funding overview
Cognition Therapeutics is based in Purchase, NY. Cognition Therapeutics has raised $36M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Grant announced in September 2022. The round record for Cognition Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Golden Seeds, Tech Coast Angels, The Michael J. Fox Foundation, NIA, ACE Fund, Dolby Family Ventures. 6 distinct backers are named across the disclosed rounds.
Cognition Therapeutics at a glance
Total raised
$36M
Latest round
Grant
Latest round date
September 2022
Headquarters
Purchase, NY
Notable investors
Golden Seeds, Tech Coast Angels, The Michael J. Fox Foundation, NIA, ACE Fund, Dolby Family Ventures
Frequently asked about Cognition Therapeutics funding
How much has Cognition Therapeutics raised?
Cognition Therapeutics has raised $36M in total disclosed funding across the rounds on record.
Who has invested in Cognition Therapeutics?
Golden Seeds, Tech Coast Angels, The Michael J. Fox Foundation, NIA, ACE Fund, Dolby Family Ventures are named among the investors backing Cognition Therapeutics.
What was the latest Cognition Therapeutics funding round?
The most recent disclosed round is a Grant, announced in September 2022.
Where is Cognition Therapeutics based?
Cognition Therapeutics is based in Purchase, NY.
When did Cognition Therapeutics last raise?
The last disclosed Cognition Therapeutics round closed in September 2022 at Grant.
Every Cognition Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Purchase at a similar stage.
